GenAI in Cybersecurity and Cybercrime: What to Expect in 2025
Join our multi-language webinar on November 21, 2024 to hone your cybersecurity skills, expand your practical knowledge and earn CPE credits.
ImmuniWeb is hosting an interactive webinar “GenAI in Cybersecurity and Cybercrime: What to Expect in 2025” for all our customers and partners who will receive personal invitations. Public is also welcome to join by a quick registration below (subject to approval).
During this 60-minute webinar you will learn about:
- Overall state of GenAI trends and developments
- GenAI in cybersecurity: myths, risks and benefits
- GenAI in cybercrime: myths, realities and threats
- Emerging AI laws and regulations to consider
- Examples of GenAI use in cybersecurity
The webinar is held in English, live subtitles are available in more than 20 languages. The webinar is held on Zoom, participants who don’t have Zoom installed on their devices can simply join via a web browser (just click on the Zoom invitation link and use “Join from your browser” option).
For convenience of the participants from different time zones, two identical sessions of the webinar will take place on:
- Session 1 – November 21, 2024 at 10am CET / 1pm GST / 5pm SGT Register
- Session 2 – November 21, 2024 at 4pm CET / 10am EDT Register
Dr. Ilia Kolochenko, Chief Architect & CEO at ImmuniWeb, will personally lead the webinar. Your questions are warmly welcome during the webinar: you can both use chat or ask live questions.
Recurrent participants may be eligible to become ImmuniWeb® Certified Professional subject to academic and professional qualifications: details will be shared during the webinar. CPE credits may be requested just after the webinar.
All our existing customers and partners will receive a personal calendar invite to join. If you don’t receive your invitation, please reach out to your account manager or simply register via one of the registration links above.
Cybersecurity Law, Regulations, and Compliance: What to Expect in 2025
Product Training: ImmuniWeb Discovery